Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Efficacy of PERT for PEI in Unresectable Pancreatic Cancer. [Phase 4]
A Phase 4 clinical trial is evaluating the efficacy of pancreatic enzyme replacement therapy (PERT) for pancreatic exocrine insufficiency in…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Fine-needle Biopsy Combined With Macroscopic On-site Evaluation for Diagnosis of Solid Pancreatic Lesions [NA]
A clinical trial evaluating fine-needle biopsy with macroscopic on-site evaluation for diagnosing solid pancreatic lesions, sponsored by Cha…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Antecolic Versus Retrocolic Gastrojejunostomy During Whipple's Procedure [NA]
This clinical trial compares antecolic vs retrocolic gastrojejunostomy during Whipple procedures in patients with resectable pancreatic canc…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection [Phase 1, Phase 2]
This update describes an ongoing Phase 1/2 clinical trial evaluating CT041 autologous CAR T-cell therapy for gastric adenocarcinoma, gastroe…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 study evaluating Hansoh's HS-10502 in adults with advanced solid tumors, including ovarian, breast, pancreatic, prostate, and colo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: CAR-NK Cells (CL-NK-001) in Pancreatic Cancer [Phase 1]
A Phase 1 trial (CL-NK-001) evaluating CAR-NK cell therapy for pancreatic cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial update indicates that Prestige Biopharma's anti-PAUF monoclonal antibody PBP1510 is entering a first-in-human Phase 1/2a…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals [EARLY_Phase 1]
This early-phase screening trial is evaluating prospective screening for pancreatic ductal adenocarcinoma in individuals at high risk.
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer [Phase 2]
Phase 2 clinical study evaluating the efficacy and safety of paclitaxel polymeric micelles for injection in patients with taxane-resistant p…
-
CLINICAL_TRIALS research · 2025-06-02Clinical Trial Update: Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery [NA]
A clinical trial evaluating a surgical technique to enucleate pancreatic tumors by blocking the abdominal trunk and superior mesenteric arte…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: A Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating Ivonescimab in combination with chemotherapy as neoadjuvant therapy for borderline resectable pancrea…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Artificial Intelligence in Endoscopic Ultrasound
A clinical trial update describes an ongoing study evaluating artificial intelligence in endoscopic ultrasound, which is currently recruitin…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for Cancer [Phase 2, Phase 3]
Phase 2/3 trial update assessing comprehensive geriatric management to reduce morbidity and improve quality of life in elderly patients unde…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer [Phase 2]
This update outlines a Phase 2 clinical trial evaluating the combination of SGT-53 with gemcitabine and nab-paclitaxel for metastatic pancre…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients [Phase 2]
Phase 2 trial evaluating modified FOLFIRINOX as adjuvant chemotherapy for pancreatic cancer in Chinese patients; currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors [Phase 1]
Phase 1 trial evaluating safety and biomarker signals for DK210, an EGFR-targeting therapy, across multiple EGFR-positive solid tumors; curr…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer [EARLY_Phase 1]
A first-in-human early-phase study of a theranostic pair using Ga-68 DOTA-5G and Lu-177 DOTA-ABM-5G for pancreatic cancer is currently recru…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)
This clinical trial assesses the diagnostic capacity of extrachromosomal circular DNAs (eccDNAs) as biomarkers for indeterminate biliary str…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating hypofractionated stereotactic body radiation therapy with 5-fluorouracil or capecitabine for locally advan…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma [Phase 1]
A Phase 1 clinical trial is evaluating Th-1 dendritic cell immunotherapy in combination with standard chemotherapy for pancreatic adenocarci…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC [Phase 1, Phase 2]
Status update on ONC-392 showing safety, pharmacokinetics, and preliminary efficacy in monotherapy and in combination with anti-PD-1 across …
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Proglumide and Chemotherapy for Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating proglumide in combination with chemotherapy for metastatic pancreatic cancer, with the study currentl…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: CEB-01 in Locally Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial update for CEB-01 in locally resectable pancreatic cancer; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors [Phase 1]
A Phase 1 trial is evaluating the addition of Elimusertib, an ATR inhibitor, to gemcitabine for advanced pancreatic and ovarian cancers and …
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors [Phase 1]
This ClinicalTrials.gov update describes a Phase 1 study evaluating MNPR-101-DFO*-89Zr as a diagnostic imaging agent for adults with various…